The 2011 edition of the six-volume BP has been optimised for easy viewing on the Apple iPad for the first time, meaning all 5,468 pages are now at your fingertips and easily portable.
First published in 1864 and legally effective in the UK from 1 January, the 2011 edition contains 51 new monographs for formulated preparations and additional standards for widely used unlicensed formulations.
To ensure individuals and organisations remain legally compliant, publisher TSO is issuing a timely reminder to place orders by 29 December (UK) or 21 December (International) to ensure the reference guide arrives before the New Year deadline.
The BP, the leading global collection of standards for UK medicinal products and pharmaceutical substances, has remained an essential reference for individuals and organisations working within pharmaceutical research and development, manufacture, and testing across the globe.
Sue Jermany, Marketing Manager for TSO, said it was important to make the publication available in as many different formats as possible and to remind customers of the looming New Year deadline.
“This is a vital publication which makes a valuable contribution to public health by setting publicly available standards for the quality of medicines,” she added.
“It’s important that we make the information as accessible as possible so people in the industry can view it at a time and place convenient to them.”
Produced by the British Pharmacopoeia Commission, it is used in almost 100 countries and its standards provide the means for an independent judgement as to the overall quality of a medicinal product.
In the latest edition, clearly laid out sections include monographs that set out the mandatory standards for active substances, excipients, formulated preparations, blood-related products, immunological products, radiopharmaceutical preparations, surgical materials, herbal and complementary medicines; together with supporting General Notices, test methods, infrared spectra and supplementary information.
European Pharmacopoeia monographs are clearly distinguished and cross-referenced while a full index assures easy access to the current legally binding UK standards.
Format options, costs and inclusions:
* Six printed volumes including a single volume of the BP (Veterinary)
* An online version via www.pharmacopoeia.co.uk (single-user licence) compatible with the iPhone and iPad
* Three free online updates in January, April and July to harmonise the BP with the European Pharmacopoeia
* European Pharmacopoeia 6th edition material up to and including Supplement 6.8
* A fully linked and searchable CD-ROM (single-user licence)
* Organisations can purchase a network licence for multiple users
* A printed copy with single-user online access and CD-ROM costs £830.00.
Orders from the UK must be placed by 29 December to ensure arrival prior to 1 January, and by 21 December for overseas orders.
The British Pharmacopoeia (BP), which is published annually, is the only comprehensive collection of standards for UK medicinal substances. It contributes to the overall control of the quality of medicinal products by providing an authoritative statement of the standard that a product is expected to meet at any time during its period of use. The publicly available and legally enforceable pharmacopoeial standards are designed to complement and assist the MHRA licensing processes for medicinal products, and are part of the system for safeguarding public health. The BP is an essential reference for all individuals and organisations involved in pharmaceutical research, development, manufacture and testing of medicines.
